Markets:

Overview

News

Currencies

International

Treasuries

Zymeworks Inc. - Common Stock (NY:ZYME)

N/A UNCHANGED

Last Price Updated: 7:00 PM EST, Dec 15, 2022 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Zymeworks Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

Zymeworks Stock: A Deep Dive Into Analyst Perspectives (5 Ratings) ↗

May 07, 2024

Via Benzinga

Next-Gen Winners: 7 Tech Stocks Set to Dominate the Decade ↗

March 08, 2024

Explore top tech stocks to dominate the decade, with their fundamental leading in information technology, finance, and health care.

Via InvestorPlace

ZYME Stock Earnings: Zymeworks Beats EPS, Beats Revenue for Q4 2023 ↗

March 06, 2024

ZYME stock results show that Zymeworks beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023.

Via InvestorPlace

3 Undervalued Small-Cap Stocks to Add to Your Must-Buy List ↗

February 22, 2024

Undervalued small-cap stocks are great for investors seeking options for upside potential, typically at a cheap share price.

Via InvestorPlace

Last Call! 7 Small-Cap Stocks Ready to Explode in Value ↗

February 20, 2024

Discover the small-cap stocks in the telecommunications, biotech, research, silver, transportation, and trading, ready to explode in value.

Via InvestorPlace

Recap: Zymeworks Q3 Earnings ↗

November 07, 2023

Via Benzinga

Earnings Scheduled For March 6, 2024 ↗

March 06, 2024

Companies Reporting Before The Bell • CTS (NYSE:CTS) is estimated to report quarterly earnings at $0.14 per share on revenue of $708.85 million.

Via Benzinga

Zymeworks - Analysts Project A Big Turnaround ↗

February 20, 2024

Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer.

Via Talk Markets

7 Small-Cap Stocks With Significant Upside Potential in 2024 ↗

February 15, 2024

Dive into small-cap stocks for a mix of stability & growth, wagering on potential leaders before the market catches on.

Via InvestorPlace

3 Strong Buy Biotech Stocks to Add to Your February Must-Watch List ↗

February 06, 2024

These biotech stocks offer investors huge potential in the future. Investors may want to consider these equities to enter the industry.

Via InvestorPlace

3 Top Stocks to Buy This Winter for Sizzling Summer Gains ↗

January 31, 2024

With economic momentum accelerating, these three top stocks flying under Wall Street's radar seem poised for sizzling summer gains.

Via InvestorPlace

A Look Into Healthcare Sector Value Stocks ↗

January 22, 2024

Via Benzinga

Overview Of Value Stocks In The Healthcare Sector ↗

January 15, 2024

Via Benzinga

$10K to $100K: Small-Cap Marvels With Massive Upside ↗

January 08, 2024

Transform $10K to $100K with top small-cap stocks. Discover market marvels with massive upside for savvy investors.

Via InvestorPlace

Small-Cap Sensations: 3 Stocks Predicted for Massive Growth in 2024 ↗

December 26, 2023

These three small-cap stocks have massive return potential in 2024 and beyond, according to analyst forecasts and broader industry trends.

Via InvestorPlace

From $10k to $100k in 5 years: 3 Small-Cap Stocks to Make a Fortune ↗

December 25, 2023

Are you looking for small-cap stocks to get rich? Turn $10k to $100k in 5 years in the stock market with these stocks.

Via InvestorPlace

Want to Turn Spare Change Into $1,000? Buy These 3 Stocks Now ↗

December 18, 2023

Three high conviction stocks seem perfect for opportunistic investors and could quickly transform spare change into four-figure returns.

Via InvestorPlace

Next Wave Biotech: 3 Stocks Poised for Breakthrough Success ↗

December 13, 2023

The overall sector may be struggling after COVID, but there's still great potential in these three biotech stocks.

Via InvestorPlace

The 7 Best Bargain Growth Stocks to Buy Before 2024 ↗

December 11, 2023

These bargain growth stocks offer significant upside potential alongside decent margins of safety, for those seeking impressive value.

Via InvestorPlace

5 Value Stocks In The Healthcare Sector ↗

December 04, 2023

Via Benzinga

3 Beaten-Down Stocks to Buy for 1,000% Upside in Five Years ↗

November 30, 2023

Many stocks now trade at tempting valuations, and these three beaten-down stocks could soar 1,000% within five years.

Via InvestorPlace

7 Healthcare Stocks That Are Poised to Become the Next Unicorns ↗

November 09, 2023

Discover healthcare stocks with remarkable potential for growth and "unicorn" status in the ever-evolving world of healthcare investments.

Via InvestorPlace

A Look Into Healthcare Sector Value Stocks ↗

October 16, 2023

Via Benzinga

Earnings Scheduled For November 7, 2023 ↗

November 07, 2023

Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings for its third quarter.

Via Benzinga

5 Value Stocks To Watch In The Healthcare Sector ↗

September 25, 2023

Via Benzinga

The 7 Most Undervalued Healthcare Stocks to Buy Now: August 2023 ↗

August 16, 2023

All of these healthcare stocks to buy are underpriced and relatively stable investments over the mid-to-long term.

Via InvestorPlace

7 Small-Cap Stocks to Buy Before the Breakout ↗

July 27, 2023

If you don’t mind the extreme risks involved, growth investors should target these ideas for best small cap stocks to buy.

Via InvestorPlace

5 Value Stocks In The Healthcare Sector ↗

July 24, 2023

Via Benzinga

2 Biotech Stocks That Could Make You Richer ↗

July 14, 2023

These biotech companies are seeing a spike in revenue growth.

Via The Motley Fool

Earnings Scheduled For August 10, 2023 ↗

August 10, 2023

Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report quarterly loss at $0.39 per share on revenue of $1.60 million.

Via Benzinga

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.